May 5, 2019
Avanti Biosciences is awarded the second phase of the fast track SBIR grants from the NIA for work on Alzheimer's Disease.
July 30, 2018
Avanti Biosciences receives $300,000 SBIR Phase 1 grant from the NIDDK for the development of new therapies for the treatment of Hyperinsulinemia Hyperammonemia Syndrome in collaboration with the Children Hospital of Philadelphia (CHOP)
May 1, 2018
Avanti Biosciences open new operations in the JLAB San Diego.
August 15, 2017
October 8, 2015